Today, Red Chip announced that they have completed the company profile on Viropro. The CEO of RedChip Companies commented that he is pleased to provide investors with an in-depth profile on Viropro in order to provide comprehensive research on the company.
Viropro assists revenue producing pharmaceutical companies in South America, Asia, Africa and Eastern Europe by letting them have the opportunity to produce and commercialize their products locally. This in turn allows the pharmaceutical companies to create their products with industrial quality at a favorable price.
Let us hear your thoughts below: